NO973459L - Vismut-forbindelser - Google Patents

Vismut-forbindelser

Info

Publication number
NO973459L
NO973459L NO973459A NO973459A NO973459L NO 973459 L NO973459 L NO 973459L NO 973459 A NO973459 A NO 973459A NO 973459 A NO973459 A NO 973459A NO 973459 L NO973459 L NO 973459L
Authority
NO
Norway
Prior art keywords
bismuth compounds
bismuth
compounds
contrast
agents
Prior art date
Application number
NO973459A
Other languages
English (en)
Norwegian (no)
Other versions
NO973459D0 (no
Inventor
Jo Klaveness
Arne Berg
Torsten Almen
Klaes Golman
Michael Droege
Shi-Bao Yu
Original Assignee
Nycomed Imaging As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9501560.8A external-priority patent/GB9501560D0/en
Application filed by Nycomed Imaging As filed Critical Nycomed Imaging As
Publication of NO973459D0 publication Critical patent/NO973459D0/no
Publication of NO973459L publication Critical patent/NO973459L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/94—Bismuth compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO973459A 1995-01-26 1997-07-25 Vismut-forbindelser NO973459L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9501560.8A GB9501560D0 (en) 1995-01-26 1995-01-26 Contrast agents
US08/486,225 US5817289A (en) 1995-01-26 1995-06-07 Non-cluster type bismuth compounds
PCT/GB1996/000183 WO1996022994A1 (en) 1995-01-26 1996-01-26 Bismuth compounds

Publications (2)

Publication Number Publication Date
NO973459D0 NO973459D0 (no) 1997-07-25
NO973459L true NO973459L (no) 1997-09-25

Family

ID=26306382

Family Applications (1)

Application Number Title Priority Date Filing Date
NO973459A NO973459L (no) 1995-01-26 1997-07-25 Vismut-forbindelser

Country Status (11)

Country Link
US (1) US6117412A (ja)
EP (1) EP0805815B1 (ja)
JP (1) JPH10512877A (ja)
CN (1) CN1177357A (ja)
AU (1) AU4493796A (ja)
CA (1) CA2211873A1 (ja)
DE (1) DE69620582T2 (ja)
FI (1) FI973117L (ja)
HU (1) HUP9900428A2 (ja)
NO (1) NO973459L (ja)
WO (1) WO1996022994A1 (ja)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9501560D0 (en) * 1995-01-26 1995-03-15 Nycomed Imaging As Contrast agents
DE19635419C1 (de) * 1996-08-23 1998-08-20 Schering Ag Wismutdendrimere und ihre Verwendung als Röntgenkontrastmittel
KR100721365B1 (ko) * 2003-04-08 2007-05-23 토소가부시키가이샤 신규 비스무트 화합물, 그 제조방법 및 막의 제조방법
WO2005014567A1 (en) * 2003-08-12 2005-02-17 Biocon Limited Mycophenolic acid bismuth salt
US7632924B2 (en) 2004-06-18 2009-12-15 Ambrx, Inc. Antigen-binding polypeptides and their uses
CN1986554B (zh) * 2005-12-20 2010-08-11 上海化学试剂研究所 三(4-乙氧基苯基)铋的制备方法
CA2699394C (en) 2007-09-17 2020-03-24 The Regents Of The University Of California Internalizing human monoclonal antibodies targeting prostate cancer cells in situ
WO2009143388A2 (en) * 2008-05-21 2009-11-26 Carnegie Mellon University Luminescent multimodal nanoparticle probe system and method of manufacture thereof
CN105388287A (zh) 2011-03-11 2016-03-09 内布拉斯加大学董事委员会 冠状动脉疾病的生物标志物
CN103771456A (zh) * 2012-10-26 2014-05-07 吴学文 一种铁氰化铋化合物及其纳米ct造影剂的制备方法
JP6460937B2 (ja) * 2014-12-04 2019-01-30 信越化学工業株式会社 末端にアミノ基を有するポリアルキレングリコール誘導体の製造方法
US10377775B2 (en) 2014-12-04 2019-08-13 Shin-Etsu Chemical Co., Ltd. Method for producing polyalkylene glycol derivative having amino group at end
US9708350B2 (en) 2014-12-04 2017-07-18 Shin-Etsu Chemical Co., Ltd. Method for producing polyalkylene glycol derivative having amino group at end, polymerization initiator for use in the same, and alcohol compound as raw material for the polymerization initiator
SI3383920T1 (sl) 2015-11-30 2024-06-28 The Regents Of The University Of California Dostava tumorsko specifičnega koristnega tovora in imunska aktivacija z uporabo humanega protitelesa, ki cilja visoko specifičen površinski antigen tumorskih celic
WO2018089829A1 (en) 2016-11-10 2018-05-17 Fortis Therapeutics, Inc. Cd46-specific effector cells and uses thereof
EP3766892A4 (en) 2018-03-16 2021-11-24 Tokuyama Corporation BISMUTH COMPOUND, HARDENABLE COMPOSITION AND HARDENED PRODUCT
EP4183579A4 (en) 2020-07-17 2024-09-11 Tokuyama Corporation Curable composition and cured body of same
EP4192511A1 (en) 2020-08-07 2023-06-14 Fortis Therapeutics, Inc. Immunoconjugates targeting cd46 and methods of use thereof

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1003685A (en) * 1961-06-29 1965-09-08 American Cyanamid Co Improvements in or relating to germicidal finishes
US3239411A (en) * 1962-06-14 1966-03-08 M & T Chemicals Inc Organo bismuth biocide
US3247050A (en) * 1962-10-11 1966-04-19 M & T Chemicals Inc Organo bismuth biocide
US3466366A (en) * 1963-05-15 1969-09-09 M & T Chemicals Inc Method of controlling bacteria with an organobismuth ethylenic carboxylate and polymer thereof
US4153685A (en) * 1968-11-23 1979-05-08 Schering Corporation Bismuth complex preparations
US3753990A (en) * 1972-01-17 1973-08-21 Procter & Gamble Phenylbismuth bis(2-pyridinethiol 1-oxide)
BE809388A (en) * 1974-01-04 1974-05-02 Bismuthyl prostanoate derivs for ulcer control - in digestive system and prepd from prostanoic acid with bismuth oxide, hydroxide or salt
US4647447A (en) * 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
US4652519A (en) * 1983-02-03 1987-03-24 Yeda Research And Development Company Limited Bifunctional chelating agents and process for their production
US4588589A (en) * 1983-10-13 1986-05-13 Richardson-Vicks Inc. Antidiarrheal compositions and use thereof
US4687659A (en) * 1984-11-13 1987-08-18 Salutar, Inc. Diamide-DTPA-paramagnetic contrast agents for MR imaging
US4826673A (en) * 1985-01-09 1989-05-02 Mallinckrodt, Inc. Methods and compositions for enhancing magnetic resonance imaging
CA1282069C (en) * 1985-09-12 1991-03-26 Damon L. Meyer Antibody complexes of hapten-modified diagnostic or therapeutic agents
IT1213029B (it) * 1986-01-30 1989-12-07 Bracco Ind Chimica Spa Chelati di ioni metallici paramagnetici.
JPS63225381A (ja) * 1986-08-29 1988-09-20 Nippon Zeon Co Ltd 肝疾患治療剤
US5482700A (en) * 1987-03-31 1996-01-09 Schering Aktiengesellschaft Substituted polyamino, polycarboxy complexing agent dimers for MRI and X-ray contrast
JP2833766B2 (ja) * 1987-07-16 1998-12-09 ニユコメド・アクシエセルカペト アミノポリカルボン酸およびその誘導体
DE3887353T2 (de) * 1987-10-12 1994-05-05 Capability Services Pty Ltd Behandlungsverfahren für magen-darm-krankheiten.
CH679582A5 (ja) * 1988-07-18 1992-03-13 Glaxo Group Ltd
AU641903B2 (en) * 1988-10-26 1993-10-07 Glaxo Group Limited Carboxylic acid derivatives
US5013560A (en) * 1989-03-17 1991-05-07 The Procter & Gamble Company Microbially-stable bismuth-containing liquid pharmaceutical suspensions
JP2907299B2 (ja) * 1989-09-07 1999-06-21 ゲルゲリイ、ゲルハルト 胃酸を結合する薬学的製剤
YU45590A (sh) * 1990-03-07 1992-07-20 PLIVA FARMACEVTSKA, KEMIJSKA, PREHRAMBENA I KOZMETIČKA INDUSTRIJA s.p.o. Novi kompleksi odnosno helati antibiotika s dvovalentnim i/ili trovalentnim metalima i postupci za njihovo dobijanje
WO1992017215A1 (en) * 1990-03-28 1992-10-15 Nycomed Salutar, Inc. Contrast media
GB9009437D0 (en) * 1990-04-26 1990-06-20 Glaxo Group Ltd Chemical compounds
DE69117955T2 (de) * 1990-07-20 1996-09-19 Tillotts Pharma Ag, Ziefen Produkte und verfahren zur behandlung des verdauungskanals
GB9019875D0 (en) * 1990-09-11 1990-10-24 Glaxo Group Ltd Pharmaceutical compositions
CA2052698A1 (en) * 1990-10-11 1992-04-12 Roger G. Berlin Treatment of peptic ulcer
AU670029B2 (en) * 1991-08-05 1996-07-04 Mallinckrodt Medical, Inc. Heavy metal clusters for use as imaging agents
GB9120131D0 (en) * 1991-09-20 1991-11-06 Glaxo Group Ltd Medicaments
DK0550083T3 (da) * 1991-12-06 1999-10-11 Glaxo Group Ltd Lægemidler til behandling af inflammatoriske tilstande eller til analgesi og indeholdende et NSAID og ranitidinbismuthcitra
JP3668983B2 (ja) * 1993-08-23 2005-07-06 日産化学工業株式会社 トリス（置換フェニル）ビスマス誘導体
US5482669A (en) * 1994-05-23 1996-01-09 General Motors Corporation Pulsating gas-assisted injection molding method and apparatus
AU4173896A (en) * 1994-11-30 1996-06-19 Schering Aktiengesellschaft Use of chelate compounds as diagnostic agents in the x-ray examination of liver and bile ducts
US5672335A (en) * 1994-11-30 1997-09-30 Schering Aktiengesellschaft Use of metal complexes as liver and gallbladder X-ray diagnostic agents
GB9501560D0 (en) * 1995-01-26 1995-03-15 Nycomed Imaging As Contrast agents

Also Published As

Publication number Publication date
FI973117A7 (fi) 1997-09-25
US6117412A (en) 2000-09-12
DE69620582T2 (de) 2002-11-07
FI973117L (fi) 1997-09-25
FI973117A0 (fi) 1997-07-25
EP0805815A1 (en) 1997-11-12
EP0805815B1 (en) 2002-04-10
AU4493796A (en) 1996-08-14
CA2211873A1 (en) 1996-08-01
JPH10512877A (ja) 1998-12-08
WO1996022994A1 (en) 1996-08-01
DE69620582D1 (de) 2002-05-16
CN1177357A (zh) 1998-03-25
HUP9900428A2 (hu) 1999-06-28
NO973459D0 (no) 1997-07-25
MX9705609A (es) 1997-10-31

Similar Documents

Publication Publication Date Title
NO973459L (no) Vismut-forbindelser
NO923821L (no) Diagnostiske midler
CL2004001126A1 (es) Complejos de polimeros en cascada y sus composiciones farmaceuticas, utiles para la preparacion de agentes de diagnostico por nmr.
NO910711D0 (no) Middel bestaaende av cavitat- eller clathrat- dannende vert/gjest-komplekser som kontrastmiddel.
NO173429C (no) Anvendelse av ferromagnetiske partikler i kontrastmidler for NMR-avbildning
DK0531421T3 (da) Kontrastmedier til ultralydsimagografi
DE69533470D1 (de) Aus mehreren einzeleinheiten zusammengesetztes pharmazeutisches präparat, das einen protonenpumpeninhibitor enthält
AU7635396A (en) Treatment and diagnosis of infections due to helicobacter pylori
KR950700726A (ko) 치료 또는 진단용 조성물, 그 제조방법 및 용도(composition for therapeutic or diagnostic use, process for its preparation and its use)
JPS6471826A (en) Method of labeling substance by technetium or rhenium
NO971251D0 (no) Pröveenhet for engangsbruk, for undersökelse av kroppsvæske
NO962248L (no) Joderte bifenylderivater og deres diagnostiske anvendelse
DK197689D0 (da) Pyridazinderivater
BR0207327A (pt) Amino derivados de biotina e seus conjugados com agentes quelantes macrocìclicos
RU95110928A (ru) Способ диагностики бактериемии (экспресс-посев крови)
ITMI912889A1 (it) Procedimento e apparecchiatura per l'abbinamento univoco di documenti radiografici, ecografici, tomografici, angiografici, di risonanza magnetico-nucleare e, in generale di tutti quei documenti che originano da procedimenti diagnostici che producono
RU94018528A (ru) Кристаллы гидрата 14а-гидрокси-4-андростен-3,6,17-триона и способ их получения
ES517874A0 (es) Procedimiento de preparacion de derivados de diaza-3,7a-cicloherta-(j,k)-fluorenos.
RU98114307A (ru) Способ лечения бактериального вагиноза
SE9401596D0 (sv) New compounds
IT1214070B (it) Sistema medico rx diagnostico per rilevamento dei vari tipi di anomalie anatomiche uretro-vescicali
ITTO950546A0 (it) Metodo per la diagnosi di infezioni helycobacter pylori e relativo corredo diagnostico.
FI903637A0 (fi) Diagnostiska analysfoerfarande och deras anvaendning foer bestaemning av kliniska tillstaond.
Morris Coal Workers' Pneumoconiosis
IT1260535B (it) Agente per lo studio della morfologia e della quantificazione del parenchima renale funzionante, composizioni che lo contengono e loro uso in medicina nucleare